Efficacy and safety of Telitacicept in patients with IgA nephropathy

Authors

  • Dongrui Liang
  • Xiaodong Li

DOI:

https://doi.org/10.12669/pjms.39.6.8393

Keywords:

IgA nephropathy, Chronic kidney disease, Telitacicept

Abstract

doi: https://doi.org/10.12669/pjms.39.6.8393

How to cite this: Liang D, Li X. Efficacy and safety of Telitacicept in patients with IgA nephropathy. Pak J Med Sci. 2023;39(6):1897.  doi: https://doi.org/10.12669/pjms.39.6.8393

Author Biographies

Dongrui Liang

 

 

Xiaodong Li

 

 

 

Downloads

Published

2023-09-23

How to Cite

Liang, D., & Li, X. . (2023). Efficacy and safety of Telitacicept in patients with IgA nephropathy. Pakistan Journal of Medical Sciences, 39(6). https://doi.org/10.12669/pjms.39.6.8393

Issue

Vol. 39 No. 6 (2023): November - December 2023

Section

Correspondence